Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Aaron L Wiegmann"'
Publikováno v:
Aesthetic Surgery Journal Open Forum, Vol 6 (2024)
Abstract BackgroundA female's breasts are integrally tied to her identity and sense of femininity. Despite extensive study of breast aesthetics, there is no discrete formula for the “ideal breast” to guide the aesthetic surgeon. Racial and cultu
Externí odkaz:
https://doaj.org/article/2c7e6c1d39a04b67b530493fae3d2ea5
Autor:
Elizabeth S. O’Neill, MD, MPH, Aaron L. Wiegmann, MD, MS, Naomi Parrella, MD, Troy Pittman, MD, Keith Hood, MD, David Kurlander, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 12, Iss 1, p e5516 (2024)
Summary:. Obesity is a major epidemic plaguing American society. Injectable subcutaneous medications initially designed for use in type 2 diabetes management, such as semaglutide and other glucagon-like peptide-1 receptor agonists, are rapidly gainin
Externí odkaz:
https://doaj.org/article/1f9a3c12feae4e3d81b565654cdc13ed
Autor:
Michelle Y. Seu, BA, Shooka Esmaeeli, MD, Aaron L. Wiegmann, MD, MS, Jennifer Akin, MD, Taylor Jaraczewski, MS, MD, Farnaz Dadrass, BS, Thomas Q. Xu, MD, Amir H. Dorafshar, MBChB, Deana Shenaq, MD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 11, Iss 1, p e4711 (2023)
Background:. Studies have linked bibliometric indices with the academic level of plastic surgeons, but this relationship has not been explored with residency program directors (PDs). As teachers of the next generation, PDs’ academic performance is
Externí odkaz:
https://doaj.org/article/6a00a733c761432c8d5f5bb1077fe2ff
Autor:
Samantha Maasarani, Syed I. Khalid, Chantal Creighton, Athena J. Manatis-Lornell, Aaron L. Wiegmann, Samantha L. Terranella, Nicholas J. Skertich, Laura DeCesare, Edie Y. Chan
Publikováno v:
Surgery Open Science, Vol 3, Iss , Pp 2-7 (2021)
Background: In the United States, few high-quality manuscripts have directly compared the complication profiles of percutaneous endoscopic versus fluoroscopic gastrostomy. Thus, it is our goal to compare these 2 common procedures to better understand
Externí odkaz:
https://doaj.org/article/3fd4b1b536984e75b9659a3951de13d6
Autor:
Sydney H. Arnold, Alvaro A. Figueroa, Aaron L. Wiegmann, Jugyeong Lee, Soumya Padala, Fadi Hamati, Marek A. Hansdorfer, Christina Tragos
Publikováno v:
Journal of Craniofacial Surgery. 34:1045-1053
Autor:
Thomas Q. Xu, MD, Taylor J. Jarazcewski, MS, Aaron L. Wiegmann, MD, Ethan M. Ritz, MS, Todd Beck, MS, Carlos A. Q. Santos, MD, MPHS, Christina Tragos, MD, Amir H. Dorafshar, MBChB
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 7, Iss 4S, Pp 84-85 (2019)
Externí odkaz:
https://doaj.org/article/80ce8d31799942b6b109ebfbda0f037d
Autor:
Georgios Kokosis, Deana S. Shenaq, Mohammed Asif, Aaron L. Wiegmann, Keith C Hood, Ethan M. Ritz, Syed I. Khalid
Publikováno v:
Journal of Plastic, Reconstructive & Aesthetic Surgery. 74:2392-2442
Autor:
Julia Wiegmann, Syed I. Khalid, Aaron L. Wiegmann, Alfonso Torquati, Samantha Maasarani, Phillip Omotosho, Adan Z. Becerra
Publikováno v:
Annals of Surgery. 275:1-6
Objective This study investigates the rates of obesity-related cancers in patients undergoing vertical sleeve gastrectomy (VSG), Roux-en-Y gastric bypass (RYGB), or no surgical intervention. Summary background data Obesity has been previously associa
Autor:
Syed I. Khalid, Kyle B. Thomson, Samantha Maasarani, Aaron L. Wiegmann, Jenny Smith, Owoicho Adogwa, Ankit I. Mehta, Amir H. Dorafshar
Publikováno v:
World neurosurgery. 164
Cranioplasty is a common neurologic procedure, with complication rates ranging from 20% to 50%. It is hypothesized that the risks of various complications are affected by which material is used for cranioplasty.To evaluate the literature comparing ra
Autor:
Claudia B. Perez, Rosalinda Alvarado, Andrea Madrigrano, Neha Nimmagadda, Cristina O'Donoghue, Laura DeCesare, Yanyu Zhang, Nicholas J. Skertich, Aaron L. Wiegmann, Samantha Terranella
Publikováno v:
Cancer Research. 81:PS1-20
Purpose: HER2 directed neoadjuvant therapies for locally advanced HER2-positive breast cancer have improved complete pathologic response and event-free survival. For T1 breast cancer, lymph node status often determines whether neoadjuvant treatment i